NCT05381311View on ClinicalTrials.gov

Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

CompletedOBSERVATIONAL
Enrollment

1,020

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

December 11, 2022

Study Completion Date

December 11, 2022

Conditions
Prostate CancerMetastatic Hormone-sensitive Prostate Cancer
Trial Locations (1)

27701

Duke Clinical Research Institute, Durham

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT05381311 - Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study | Biotech Hunter | Biotech Hunter